BNP PARIBAS FINANCIAL MARKETS - KARUNA THERAPEUTICS INC ownership

KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 134 filers reported holding KARUNA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 2.41 and the average weighting 0.1%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of KARUNA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,223,364
+43.7%
13,149
+84.3%
0.00%
+50.0%
Q2 2023$1,547,442
-55.7%
7,136
-62.9%
0.00%
-60.0%
Q1 2023$3,496,752
-47.8%
19,251
-43.5%
0.01%
-50.0%
Q4 2022$6,694,952
-99.9%
34,071
-35.2%
0.01%
-47.4%
Q3 2022$11,820,746,000
+1496.9%
52,553
+798.2%
0.02%
+1800.0%
Q2 2022$740,210,000
+212.9%
5,851
+213.6%
0.00%
Q1 2022$236,590,000
-61.5%
1,866
-60.2%
0.00%
-100.0%
Q4 2021$614,783,000
+24.4%
4,693
+16.1%
0.00%0.0%
Q3 2021$494,336,000
+103.2%
4,041
+89.4%
0.00%
Q2 2021$243,255,000
+1.7%
2,134
+7.2%
0.00%
Q1 2021$239,258,000
+20.8%
1,990
+2.1%
0.00%
Q4 2020$197,999,000
-31.3%
1,949
-47.7%
0.00%
Q3 2020$288,094,000
+37.9%
3,726
+98.8%
0.00%
Q2 2020$208,876,000
-15.8%
1,874
-45.6%
0.00%
-100.0%
Q1 2020$247,968,000
+518.7%
3,444
+547.4%
0.00%
Q4 2019$40,081,000
+324.2%
532
-8.1%
0.00%
Q3 2019$9,449,0005790.00%
Other shareholders
KARUNA THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Pivotal bioVenture Partners Investment Advisor LLC 782,008$142,043,93358.49%
Nan Fung Group Holdings Ltd 225,688$40,993,96827.90%
Sofinnova Investments, Inc. 1,773,124$322,070,24320.60%
Artia Global Partners LP 88,831$16,135,2635.96%
DAFNA Capital Management LLC 78,573$14,272,0004.28%
First Light Asset Management, LLC 243,675$44,261,1273.98%
CATALYST PRIVATE WEALTH, LLC 21,837$3,966,4732.74%
Sands Capital Ventures, LLC 58,895$10,697,6882.64%
ARCH Venture Management, LLC 30,000$5,449,2002.63%
Logos Global Management LP 100,000$18,164,0002.60%
View complete list of KARUNA THERAPEUTICS INC shareholders